AgomAb Therapeutics NV · NASDAQ:AGMB

Epstein David R bought 5,000 AgomAb Therapeutics NV shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 19, 2026

On Nov 17, 2026, Epstein David R (Director) bought 5,000 AgomAb Therapeutics NV shares at US$5.57 for US$27,850, leaving 59,980 shares. Filed Nov 19, 2026 (Form 4).

Bought
5,000 shares
Price
US$5.57
Value
US$27,850
Holding after
59,980 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common sharesBuy5,000US$5.5759,980Direct

Source

Download original · View original at SEC

Related